Feret, W.; Nalewajska, M.; Wojczyński, Ł.; Witkiewicz, W.; Kłos, P.; Dziedziejko, V.; Pawlik, A.
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm. J. Clin. Med. 2021, 10, 5305.
https://doi.org/10.3390/jcm10225305
AMA Style
Feret W, Nalewajska M, Wojczyński Ł, Witkiewicz W, Kłos P, Dziedziejko V, Pawlik A.
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm. Journal of Clinical Medicine. 2021; 10(22):5305.
https://doi.org/10.3390/jcm10225305
Chicago/Turabian Style
Feret, Wiktoria, Magdalena Nalewajska, Łukasz Wojczyński, Wojciech Witkiewicz, Patrycja Kłos, Violetta Dziedziejko, and Andrzej Pawlik.
2021. "Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm" Journal of Clinical Medicine 10, no. 22: 5305.
https://doi.org/10.3390/jcm10225305
APA Style
Feret, W., Nalewajska, M., Wojczyński, Ł., Witkiewicz, W., Kłos, P., Dziedziejko, V., & Pawlik, A.
(2021). Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm. Journal of Clinical Medicine, 10(22), 5305.
https://doi.org/10.3390/jcm10225305
